• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ST. JUDE MEDICAL, INC. LIVEWIRE¿ TC ABLATION CATHETER; CARDIAC ABLATION PERCUTANEOUS CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ST. JUDE MEDICAL, INC. LIVEWIRE¿ TC ABLATION CATHETER; CARDIAC ABLATION PERCUTANEOUS CATHETER Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Heart Block (4444)
Event Type  Injury  
Event Description
The following was published in herzschrittmachertherapie & elektrophysiologie (nov 10, 2023) "zero-fluoro atrioventricular-nodal reentrant tachycardia ablation"; soether, christina the authors retrospectively analyzed 68 patients that underwent avnrt-rfca.One group was a priori allocated to conventional fluoroscopy mapping.In 38 cases, the electrophysiologist chose to use 3d-eam for ablation.Of these patients, 20 could be ablated without fluoroscopy use (zerofluoro).In 18 cases that were initially intended as 3d-eam, additional fluoroscopy use was necessary due to difficult anatomic conditions (convertedfluoro).Procedure duration, fluoroscopy duration and dose, as well as complications were analyzed.Procedure duration was similar for the convfluoro and zerofluoro groups.The convertedfluoro group showed longer procedure duration compared to the convfluoro group.The use of 3d-eam significantly reduced fluoroscopy duration comparing the convfluoro with the convertedfluoro group.The difference in fluoroscopy dose between convfluoro and converted fluoro did not reach significance.In zerofluoro cases, no radiation was used at all.3d-eam-guided rfca was primarily successful in all patients.Overall, there were only few minor complications in the different groups.No major complications occurred.One transient right bundle branch block (rbbb), four transient atrioventricular (av) block iii and one av block ii occurred with full recovery each.No major (persistent) complications occurred in any group.
 
Manufacturer Narrative
Additional information: d9, g1, g3, h2, h3, h6 the results of the investigation are inconclusive since the device was not returned for analysis.Review of the device history record was not possible as the lot number is unknown.Based on the information received, the cause of the reported incident could not be conclusively determined.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
LIVEWIRE¿ TC ABLATION CATHETER
Type of Device
CARDIAC ABLATION PERCUTANEOUS CATHETER
Manufacturer (Section D)
ST. JUDE MEDICAL, INC.
14901 deveau place
minnetonka MN 55345
Manufacturer (Section G)
ST. JUDE MEDICAL, INC.
14901 deveau place
minnetonka MN 55345
Manufacturer Contact
janna parks
5050 nathan lane north
plymouth, MN 55442
6517565400
MDR Report Key18248184
MDR Text Key329501471
Report Number2182269-2023-00055
Device Sequence Number1
Product Code LPB
Combination Product (y/n)N
Reporter Country CodeGM
PMA/PMN Number
P960016
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Literature
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 01/09/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/01/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Date Manufacturer Received12/22/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Life Threatening;
-
-